also known ultralongacting adrenoreceptor ultralaba investigated treatment asthma copd utilizes sulfonamide agonist headgroup confers high levels intrinsic crystallinity could relate acidic sulfonamide motif supporting zwitterionic form solid state optimization pharmacokinetic properties minimized systemic exposure following inhalation reduced systemically mediated adverse vivo duration action confirmed potential oncedaily use humans investigation development discontinued likely strategic regulatory drug article relating respiratory system stub help wikipedia expanding